References
1. Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of
hematologic malignancies on the basis of genetics. Blood. 2017 Jul
27;130(4):410–23.
2. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and
adolescent cancer statistics, 2014. CA Cancer J Clin.
2014;64(2):83–103.
3. Yassin MA, Taher A, Mathews V, Hou HA, Shamsi T, Tuğlular TF, Xiao Z,
Kim SJ, Depei W, Li J, Rippin G. MERGE: a multinational, multicenter
observational registry for myeloproliferative neoplasms in Asia,
including Middle East, Turkey, and Algeria. Cancer Medicine. 2020 Apr
30.
4. Yassin MA, Abdulla MA, Chandra P, Aldapt MB, Hamad Y, Akiki SJ,
Kassem N, Nashwan AJ, Nur U. Chronic Myeloid Leukemia in Adolescents and
Young Adults: A Single Institute Experience. Blood, (2019): 5915-5915
5. Ebert EC, Hagspiel KD. Gastrointestinal manifestations of leukemia. J
Gastroenterol Hepatol. 2012;27(3):458–63.
6. Turkina A, Wang J, Mathews V, Saydam G, Jung CW, Al Hashmi HH, Yassin
M, Le Clanche S, Miljkovic D, Slader C, Hughes TP. TARGET: a survey of
real‐world management of chronic myeloid leukaemia across 33 countries.
British Journal of Haematology. 2020 Mar 30.
7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et
al. The 2016 revision of the World Health Organization classification of
lymphoid neoplasms. Blood. 2016 May 19;127(20):2375–90.
8. Cornes JS, Jones TG. Leukaemic lesions of the gastrointestinal tract.
J Clin Pathol. 1962 Jul;15:305–13.
9. Wallace J, Schwaitzberg S, Miller K. Sometimes it really is
appendicitis: case of a CML patient with acute appendicitis. Ann
Hematol. 1998 Aug;77(1–2):61–4.
10. Nacif LS, Waisberg DR, Pinheiro RS, Lima FR, Rocha-Santos V, Andraus
W, et al. Imatinib-induced fulminant liver failure in chronic myeloid
leukemia: role of liver transplant and second-generation tyrosine kinase
inhibitors: a case report. J Med Case Reports. 2018 Mar 10;12(1):63.
11. Yassin MA, Nashwan AJ, Soliman AT, Yousif A, Moustafa A, AlBattah A,
et al. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with
Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront
Therapy. Clin Med Insights Case Rep. 2015;8:77–81.
12. Lubna M. Riaz, Khaled M. Galal, Radwa M. Hussein, Abdulqadir J.
Nashwan, Mohamed A. Yassin. Dasatinib-Induced Colitis in a Patient with
Chronic Myeloid Leukemia (Chronic Phase). International Journal of Case
Reports, 2018 3:43. DOI:10.28933/ijcr-2018-10-240